{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:06:26Z","timestamp":1789722386374,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56AR055966"],"award-info":[{"award-number":["R56AR055966"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bone.2017.10.012","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T08:00:15Z","timestamp":1507881615000},"page":"103-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent"],"prefix":"10.1016","volume":"106","author":[{"given":"S.E.","family":"Tahaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Couasnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Paria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.F.","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2972-5633","authenticated-orcid":false,"given":"F.","family":"Elefteriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.10.012_bb0005","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jmg.26.11.704","article-title":"A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity","volume":"26","author":"Huson","year":"1989","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bone.2017.10.012_bb0010","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/ajmg.a.33045","article-title":"Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options","volume":"149A","author":"Elefteriou","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bone.2017.10.012_bb0015","first-page":"575","article-title":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference","volume":"45","author":"Stumph","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bone.2017.10.012_bb0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng0794-353","article-title":"Tumour predisposition in mice heterozygous for a targeted mutation in Nf1","volume":"7","author":"Jacks","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.10.012_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00003086-200208000-00013","article-title":"Orthopaedic manifestations of neurofibromatosis in children: an update","author":"Vitale","year":"2002","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2017.10.012_bb0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/(SICI)1096-8628(19960726)67:4<421::AID-AJMG20>3.0.CO;2-K","article-title":"Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene","volume":"67","author":"Upadhyaya","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bone.2017.10.012_bb0035","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/jbmr.2298","article-title":"Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1","volume":"29","author":"Paria","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.10.012_bb0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/504441","article-title":"Double inactivation of NF1 in tibial pseudarthrosis","volume":"79","author":"Stevenson","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2017.10.012_bb0045","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1093\/hmg\/ddr310","article-title":"Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I","volume":"20","author":"Wang","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2017.10.012_bb0050","article-title":"Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1OSX (\u2212\/\u2212) mice","author":"de la Croix Ndong","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.10.012_bb0055","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/hmg\/ddt162","article-title":"The ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation","volume":"22","author":"Ono","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2017.10.012_bb0060","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/hmg\/ddv019","article-title":"FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation","volume":"24","author":"Karolak","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2017.10.012_bb0065","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1172\/JCI29092","article-title":"Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions","volume":"116","author":"Yang","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.10.012_bb0070","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1093\/hmg\/ddr310","article-title":"Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I","volume":"20","author":"Wang","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2017.10.012_bb0075","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nm.3583","article-title":"Asfotase-\u03b1 improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1","volume":"20","author":"de la Croix Ndong","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.10.012_bb0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/BPO.0b013e31828121b8","article-title":"Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 bone abnormalities consortium","volume":"33","author":"Stevenson","year":"2013","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bone.2017.10.012_bb0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/(SICI)1096-8628(19990611)84:5<413::AID-AJMG5>3.0.CO;2-1","article-title":"Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1","volume":"84","author":"Stevenson","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bone.2017.10.012_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01202412-200001000-00002","article-title":"Pathology of bone lesions associated with congenital pseudarthrosis of the leg","volume":"9","author":"Ippolito","year":"2000","journal-title":"J. Pediatr. Orthop. B"},{"key":"10.1016\/j.bone.2017.10.012_bb0095","article-title":"rhBMP-2 and intramedullary fixation in congenital pseudarthrosis of the tibia","author":"Richards","year":"2016","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bone.2017.10.012_bb0100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.bpb.0000194439.75378.ac","article-title":"Treatment of a congenital pseudarthrosis of the tibia by osteogenic protein-1 (bone morphogenetic protein-7): a case report","volume":"15","author":"Anticevic","year":"2006","journal-title":"J. Pediatr. Orthop. B"},{"key":"10.1016\/j.bone.2017.10.012_bb0105","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2106\/JBJS.D.02201","article-title":"Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7): a report of five cases","volume":"os-88","author":"Lee","year":"2006","journal-title":"JBJS Case Connect."},{"key":"10.1016\/j.bone.2017.10.012_bb0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1302\/0301-620X.88B1.16619","article-title":"Bone morphogenetic protein 7 in the treatment of congenital pseudarthrosis of the tibia","volume":"88\u2013B","author":"Fabeck","year":"2006","journal-title":"J. Bone Jt. Surg. - Br."},{"key":"10.1016\/j.bone.2017.10.012_bb0115","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.M.00862","article-title":"A combination of rhBMP-2 (recombinant human bone morphogenetic protein-2) and MEK (MAP kinase\/ERK kinase) inhibitor PD0325901 increases bone formation in a murine model of neurofibromatosis type I pseudarthrosis","volume":"96","author":"El-Hoss","year":"2014","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2017.10.012_bb0120","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","article-title":"NF1 tumor suppressor gene function: narrowing the GAP","volume":"104","author":"Cichowski","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bone.2017.10.012_bb0125","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1093\/hmg\/ddt333","article-title":"Hyperactive Ras\/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice","volume":"22","author":"Sharma","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2017.10.012_bb0130","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1101\/gad.261677.115","article-title":"Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathways","volume":"29","author":"Chen","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.bone.2017.10.012_bb0135","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.2106\/JBJS.H.00014","article-title":"Biologic characteristics of fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1","volume":"90","author":"Cho","year":"2008","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2017.10.012_bb0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4055\/cios.2011.3.3.230","article-title":"Disturbed osteoblastic differentiation of fibrous hamartoma cell from congenital pseudarthrosis of the tibia associated with neurofibromatosis type I","volume":"3","author":"Lee","year":"2011","journal-title":"Clin. Orthop. Surg."},{"key":"10.1016\/j.bone.2017.10.012_bb0145","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/hmg\/ddl208","article-title":"Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem\/progenitor cells","volume":"15","author":"Wu","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2017.10.012_bb0150","doi-asserted-by":"crossref","first-page":"12345","DOI":"10.3390\/ijms160612345","article-title":"Hyperactive RAS\/PI3-K\/MAPK signaling cascade in migration and adhesion of Nf1 haploinsufficient mesenchymal stem\/progenitor cells","volume":"16","author":"Zhou","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2017.10.012_bb0155","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/jbmr.1992","article-title":"Hyperactive transforming growth factor-\u03b21 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model","volume":"28","author":"Rhodes","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.10.012_bb0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semcdb.2014.03.005","article-title":"Epiregulin: roles in normal physiology and cancer","volume":"28","author":"Riese","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bone.2017.10.012_bb0165","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1074\/jbc.275.8.5748","article-title":"Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes","volume":"275","author":"Shirakata","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.10.012_bb0170","first-page":"7495","article-title":"Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes","volume":"270","author":"Toyoda","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.10.012_bb0175","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/jcb.23094","article-title":"EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix","volume":"112","author":"Zhu","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bone.2017.10.012_bb0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00223001128","article-title":"Down-regulation of osteoblastic cell differentiation by epidermal growth factor receptor","volume":"67","author":"Chien","year":"2000","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2017.10.012_bb0185","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1074\/jbc.M409807200","article-title":"Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation","volume":"280","author":"Qin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.10.012_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.363","article-title":"Heparin-binding EGF-like growth factor and miR-1192 exert opposite effect on Runx2-induced osteogenic differentiation","volume":"4","author":"Yu","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bone.2017.10.012_bb0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood-2004-09-3645","article-title":"HB-EGF\/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation","volume":"106","author":"Krampera","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bone.2017.10.012_bb0200","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jbmr.5650020505","article-title":"Biphasic effects of epidermal growth factor on bone nodule formation by isolated rat calvaria cells in vitro","volume":"2","author":"Antosz","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.10.012_bb0205","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0169-6009(90)90117-X","article-title":"Effects of acidic fibroblast growth factor and epidermal growth factor on subconfluent fetal rat calvaria cell cultures: DNA synthesis and alkaline phosphatase activity","volume":"8","author":"Nicolas","year":"1990","journal-title":"Bone Miner."},{"key":"10.1016\/j.bone.2017.10.012_bb0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00441-010-0929-0","article-title":"Betacellulin inhibits osteogenic differentiation and stimulates proliferation through HIF-1alpha","volume":"340","author":"Genetos","year":"2010","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bone.2017.10.012_bb0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1247\/csf.10001","article-title":"Potential involvement of Twist2 and Erk in the regulation of osteoblastogenesis by HB-EGF-EGFR signaling","volume":"35","author":"Nakamura","year":"2010","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.bone.2017.10.012_bb0220","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/jbmr.42","article-title":"Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts","volume":"25","author":"Wang","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.10.012_bb0225","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201500190RR","article-title":"\u03b2-catenin modulation in neurofibromatosis type 1 bone repair: therapeutic implications","author":"Ghadakzadeh","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2017.10.012_bb0230","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nm.1943","article-title":"Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis","volume":"15","author":"Korpal","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.10.012_bb0235","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0092-8674(81)90100-8","article-title":"Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells","volume":"24","author":"Hunter","year":"1981","journal-title":"Cell"},{"key":"10.1016\/j.bone.2017.10.012_bb0240","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1126\/science.8066447","article-title":"A specific inhibitor of the epidermal growth factor receptor tyrosine kinase","volume":"265","author":"Fry","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bone.2017.10.012_bb0245","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2011.01.010","article-title":"Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer","volume":"302","author":"Nam","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bone.2017.10.012_bb0250","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00030.2015","article-title":"Expression and function of the epidermal growth factor receptor in physiology and disease","volume":"96","author":"Chen","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bone.2017.10.012_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2005.033522","article-title":"Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment","volume":"43","author":"Janssens","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bone.2017.10.012_bb0260","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.1964.03060200022003","article-title":"Skeletal manifestations in the Marfan syndrome","volume":"187","author":"Wilner","year":"1964","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2017.10.012_bb0265","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/ajmg.a.33356","article-title":"Germline TGF-? receptor mutations and skeletal fragility: a report on two patients with Loeys-Dietz syndrome","volume":"152A","author":"Kirmani","year":"2010","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.bone.2017.10.012_bb0270","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.140.8.2661","article-title":"Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells","volume":"140","author":"Ottmann","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2017.10.012_bb0275","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1016\/S0021-9258(18)61441-3","article-title":"The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts","volume":"262","author":"Fine","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.10.012_bb0280","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1093\/emboj\/20.9.2254","article-title":"TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation","volume":"20","author":"Alliston","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2017.10.012_bb0285","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/sj.emboj.7600729","article-title":"Repression of Runx2 function by TGF-\u03b2 through recruitment of class II histone deacetylases by Smad3","volume":"24","author":"Kang","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2017.10.012_bb0290","doi-asserted-by":"crossref","first-page":"35975","DOI":"10.1074\/jbc.M112.372458","article-title":"Transforming growth factor \u03b2 suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis","volume":"287","author":"Lian","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.10.012_bb0295","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.cellsig.2013.07.007","article-title":"Induction of renal fibrotic genes by TGF-\u03b21 requires EGFR activation, p53 and reactive oxygen species","volume":"25","author":"Samarakoon","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bone.2017.10.012_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.3155","article-title":"Targeted disruption of NF1 in osteocytes increases FGF23 and osteoid with osteomalacia-like bone phenotype","author":"Kamiya","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.10.012_bb0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bone.2017.02.012","article-title":"Pharmacologically targeting beta-catenin for NF1 associated deficiencies in fracture repair","volume":"98","author":"Baht","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.10.012_bb0310","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.862101","article-title":"Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain","volume":"15","author":"Zhu","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.bone.2017.10.012_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.3133","article-title":"Skeletal colonization by breast cancer cells is stimulated by an osteoblast and \u03b22AR-dependent neo-angiogenic switch","author":"Mulcrone","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.10.012_bb0320","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1089\/hum.2005.16.1287","article-title":"Novel compound enables high-level adenovirus transduction in the absence of an adenovirus-specific receptor","volume":"16","author":"Fouletier-Dilling","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bone.2017.10.012_bb8000","first-page":"895","article-title":"FLEXBAR\u2014Flexible Barcode and Adapter Processing for Next-Generation Sequencing Platforms","volume":"1","author":"Dodt","year":"2012","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.bone.2017.10.012_bb9000","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods."},{"key":"10.1016\/j.bone.2017.10.012_bb0325","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bone.2017.10.012_bb0330","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217303782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217303782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:39:59Z","timestamp":1757612399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217303782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":68,"alternative-id":["S8756328217303782"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.10.012","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}